Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Intersect ENT revenue
Intersect ENT's revenue is $106.7 million.
What is Intersect ENT's revenue?
- Intersect ENT's revenue growth from 2013 to 2021 is 495.33%.
- Intersect ENT has 393 employees, and the revenue per employee ratio is $271,623.
- Intersect ENT's peak quarterly revenue was $32.8M in 2018(q4).
- Intersect ENT peak revenue was $109.1M in 2019.
- Intersect ENT annual revenue for 2020 was 80.6M, -26.19% growth from 2019.
- Intersect ENT annual revenue for 2021 was 106.7M, 32.52% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Intersect ENT historical revenue
Intersect ENT's peak revenue was $109.1M in 2019. The peak quarterly revenue was $32.8M in 2018(q4).
Intersect ENT's revenue increased from $17.9m in 2013 to $106.7M currently. That's a 495.33% change in annual revenue.
Intersect ENT annual revenue
Intersect ENT annual revenue over time
| Fiscal year / year | Intersect ENT revenue |
|---|---|
| 2013 | $17.9M |
| 2014 | $38.6M |
| 2015 | $61.6M |
| 2016 | $78.7M |
| 2017 | $96.3M |
| 2018 | $108.5M |
| 2019 | $109.1M |
| 2020 | $80.6M |
| 2021 | $106.7M |
Rate Intersect ENT's financial transparency
Intersect ENT annual growth
Intersect ENT saw the greatest revenue growth in 2014, when revenue increased by 115.2%.
Intersect ENT had the lowest revenue growth in 2020, when revenue changed by -26.19%.
Intersect ENT annual growth rate over time
| Year | Intersect ENT growth |
|---|---|
| 2014 | 115%↑ |
| 2015 | 60%↑ |
| 2016 | 28%↑ |
| 2017 | 22%↑ |
| 2018 | 13%↑ |
| 2019 | 1%↑ |
| 2020 | -26%↓ |
| 2021 | 33%↑ |
Intersect ENT quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Intersect ENT quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | $8.6M | $9.1M | $13.4M |
| 2015 | $13.4M | $15.2M | $14.2M | $18.8M |
| 2016 | $16.7M | $19.3M | $18.5M | $24.2M |
| 2017 | $20.5M | $24.0M | $22.3M | $29.5M |
| 2018 | $24.7M | $26.3M | $24.7M | $32.8M |
| 2019 | $26.7M | $26.7M | $24.1M | $31.8M |
| 2020 | $19.8M | $9.8M | $22.7M | $28.2M |
| 2021 | $24.3M | $27.3M | $24.4M | $30.7M |
| 2022 | $21.6M | - | - | - |
Intersect ENT jobs nearby
Do you work at Intersect ENT?
Did Intersect ENT meet its revenue projections?
Intersect ENT financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 393 |
| Date Founded | 2003 |
| Headquarters | Menlo Park, California |
| Number of Locations | 2 |
| Revenue | $106.7M |
| Net Income | -$159,635,000 |
| Gross Proft | $76.7M (2021) |
| PE Ratio | -5.55 |
| Tax Rate | 0.0% |
| Market Capitalization | $885.5M |
| Total Assets | $146,867,000 |
| Ticker | XENT |
Intersect ENT jobs you might like
Intersect ENT financing
Intersect ENT received early financing of $3.5M on 2007-09-20.
| Series | Round size | Date |
|---|---|---|
| Series A | $3.5M | 09/2007 |
| Series B | $20M | 06/2008 |
| Series C | $31M | 10/2010 |
| Series D | $30M | 02/2013 |
| Series Unknown | $18.3M | 02/2013 |
| Post Ipo Equity | $65M | 05/2020 |
Intersect ENT investors
| Investors | Security type |
|---|---|
| U.S. Venture Partners (USVP) | Series A |
| U.S. Venture Partners (USVP) | Series B |
| PTV Healthcare Capital | Series B |
| U.S. Venture Partners (USVP) | Series C |
| Norwest Venture Partners | Series C |
| Kleiner Perkins | Series C |
| PTV Healthcare Capital | Series C |
| Medtronic plc | Series C |
| U.S. Venture Partners (USVP) | Series D |
| Norwest Venture Partners | Series D |
| Kleiner Perkins | Series D |
| Harmony Partners | Series D |
| PTV Healthcare Capital | Series D |
| Deerfield Management | Post Ipo Equity |
Intersect ENT competitors
Intersect ENT's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Intersect ENT's smallest competitor is Ardent Technologies with revenue of $1.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| ResMed | $87,267 | $4.7B | 8,000 | 166 |
| Boston Scientific | $60,291 | $16.7B | 36,000 | 700 |
| Stryker | $69,470 | $22.6B | 43,000 | 2,067 |
| Varian Medical Systems | $104,569 | $3.2B | 10,000 | 11 |
| Dexcom | $78,550 | $4.0B | 3,900 | 173 |
| Hospira | $64,435 | $4.5B | 19,000 | - |
| Danaher | $65,463 | $23.9B | 80,000 | 1,749 |
| Intuitive Surgical | $113,813 | $8.4B | 5,527 | 245 |
| Amgen | $93,349 | $33.4B | 22,000 | 599 |
| Ardent Technologies | $73,368 | $1.6M | 30 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Intersect ENT highest paying jobs
Zippia gives an in-depth look into the details of Intersect ENT, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Intersect ENT. The employee data is based on information from people who have self-reported their past or current employments at Intersect ENT. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Intersect ENT. The data presented on this page does not represent the view of Intersect ENT and its employees or that of Zippia.
Intersect ENT may also be known as or be related to INTERSECT ENT INC., Intersect ENT, Intersect ENT Inc, Intersect ENT, Inc. and Intersect Ent, Inc.